• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Poll: Boomers unsettled about Medicare | MassDevice On Call

Poll: Boomers unsettled about Medicare | MassDevice On Call

December 30, 2010 By MassDevice staff

MassDevice On Call

Poll: Boomers unsettled about Medicare. As baby boomer generation begins to qualify for Medicare, many of them fear that they won’t be able to rely on the federally-funded health insurance plan through their golden years. A new Associated Press-GfK poll finds that 43 percent of Americans born between 1946 and 1964 say they don’t expect to be able to depend on Medicare forever, while 20 percent think their Medicare is secure. The rest have mixed feelings about the government-run health plan, reports The Washington Post.

Spinal cord repair, an update: Scientists have produced a steady stream of promising discoveries–treatments that promote nerve growth in the laboratory dish and animals, even some reports of paralyzed rodents regaining motor function. So why are people with spinal cord injury (SCI) still without therapies that repair their nerve damage? Children’s Hospital Boston’s Vector Blog rounds up the current state of science on SCI treatment.

A Health IT wish list for 2011: Healthcare blogger and consultant David Williams went to Twitter to ask for help on what will happen in healthcare in 2011. What he essentially got comprises a wish list for Health IT. Williams wrote up the predictions in his Health Business Blog.

Why bad doctors stay doctors. ReportingOnHealth completed a yearlong, nationwide tour reviewing medical boards and doctors’ disciplinary files. Eighty-two percent of the 51 doctors they highlighted in their Doctors Behaving Badly series are still practicing (and when they say behaving badly, they mean injuring or killing 290 patients).

How do states contribute to keeping bad doctors in play? NPR summed up their findings this way:

  1. States tend to set age limits on the people who can be seen by doctors who’ve shown a tendency to molest patients. A more prudent course, he says, would be to ban these doctors from seeing patients altogether or to require a chaperone for all.
  2. Many states push problem doctors into areas where patients are particularly vulnerable, such asprisons and poor neighorhoods.
  3. Medical boards are slow to act even when doctors have already been in trouble with the law, including the Drug Enforcement Agency.

FDA’s limits on mobile health devices? Tough questions from the mHealth Regulatory Coalition’s 60-page whitepaper: “Is a software app stored on a mobile phone regulated as a medical device if it asks the patient questions and transmits the patient’s answers to a health care provider? Does the Food & Drug Administration plan to regulate decision support software residing on a physician’s mobile phone that offers a preliminary analysis of data received from the patient? Would software that sends a doctor an alert based on changes in a consumer’s weight require prior clearance from the FDA?” (Read the executive summary)

Life science stocks: 2010 winners and losers. The winners: CardioVascular Systems, Exact Scientific, Exelixis and NeoGen. The losers: Celera, Cephalon and Gilead.

Doryx, FORTESTA FDA approvals. Endo Pharmaceuticals new topical to help men with low testosterone received FDA approval, as did IMPAX Laboratories’ generic version of Doryx, Warner Chilcott’s acne drug.

Nurses v. Doctors. “Nurses are warm, whereas doctors are cool. Nurses act like real people; doctors often act like aristocrats. Nurses look you in the eye; doctors stare slightly above and to the right of your shoulder.” (From a New York Times article called, In Praise of Nurses)

Dealflow and more. Central Illinois medical investor Open Prairie caps its second fund at $30 million; China’s Kangmei Pharmaceutical will raise up to $529 million by selling new shares to existing shareholders; Provectus Pharmaceuticals, which makes oncology and dermatology drugs, has raised $1 million; Canada’s CardioComm Solutions, which digitally manages electrocardiograms, raised $300,000.

Material from MedCity News was used in this report.

Filed Under: Business/Financial News, Healthcare Reform, News Well

In case you missed it

  • Ambu replaces CEO with new leadership
  • Moderna’s first bivalent COVID-19 vaccine booster candidate shows promise
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
  • FDA clears Accelus’ Toro-L interbody fusion system
  • Teleflex’s UroLift cleared in China to treat BPH
  • Globus Medical announces first surgeries with Excelsius3D
  • Abbott reports positive data on heart valve therapies
  • OncoRes Medical raises another $12.5M
  • NeuroMetrix’s Quell neuromodulation device wins FDA de novo nod to treat fibromyalgia
  • Inogen appoints Agnes Lee as senior VP of investor relations, strategic planning
  • Google Health hires FDA’s chief digital health officer
  • ApiJect picks up $111M investment from Royalty Pharma, Jefferies
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
  • Teleflex wins Health Canada nod for Manta vascular closure device
  • Study shows strong performance, improved outcomes with Medtronic Evolut TAVR
  • New FDA clearance expands indications for Xact Robotics’ ablation system
  • Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy

RSS From Medical Design & Outsourcing

  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]
  • How Minnetronix Medical helped Lazurite with its wireless surgical camera
    Minnetronix Medical (St. Paul, Minnesota) has played an important development and manufacturing partner role with Lazurite’s wireless surgical camera system. It’s been nearly two months since Lazurite (formerly Indago) announced FDA 510(k) clearance of its ArthroFree system. ArthroFree combines proprietary low-heat, high-intensity Meridiem light engine technology with advanced camera, battery and wireless transmission technologies and… […]
  • Instron releases TrendTracker data analysis workflow platform
    Instron announced that it released the TrendTracker module in Bluehill Central for accelerating data analysis workflows. Norwood, Massachusetts-based Instron designed TrendTracker with an intuitive interface to improve the data analysis workflow of single or multi-location materials testing laboratories. According to a news release, the platform features quick searching and the ability to display and analyze… […]
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
    Henry Schein (Nasdaq:HSIC) today named Dirk Benson as VP and chief commercial officer of the medical device manufacturer and distributor’s North America Distribution Group (NADG). Melville, New York-based Henry Schein is the world’s largest provider of health care supplies and services for office-based dental and medical practitioners, and NADG is the company’s largest business group. The… […]
  • The road to a robot: Medtronic’s development process for its Hugo RAS system
    Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they eat a lot, making… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS